Equity strategies

Carmignac Portfolio Grandchildren

Global marketArticle 9
Share Class

LU1966631001

An intergenerational Fund focused on quality, sustainable companies
  • A Fund focused on selecting high-quality companies around the world, with sound financials and sustainable profitability.
  • An investment process based on rigorous fundamental analysis, quantitative screening, and a socially responsible investment approach.
  • A concentrated, low turnover portfolio of high-conviction names seeking to provide steady growth of your capital over the long term.
Key documents
Asset Allocation
Equities95.6 %
Other4.4 %
Data as of:  Nov 28, 2025.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
+ 95.9 %
-
+ 39.1 %
+ 41.9 %
- 4.6 %
From 31/05/2019
To 08/01/2026
Calendar Year Performance 2025
-
-
-
+ 15.5 %
+ 20.3 %
+ 28.4 %
- 24.2 %
+ 23.0 %
+ 21.9 %
- 5.1 %
Net Asset Value
195.89 €
Asset Under Management
422 M €
Net Equity Exposure28/11/2025
95.6 %
SFDR - Fund Classification

Article

9
Data as of:  Jan 8, 2026.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.

Carmignac Portfolio Grandchildren fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  Dec 31, 2025.
Fund management team
[Management Team] [Author] Denham Mark

Mark DENHAM

Head of Equities, Fund Manager
[Management Team] [Author] Ejikeme Obe

Obe EJIKEME

Fund Manager, Analyst

Market environment

  • 2025 marked the third consecutive year in which global equity markets delivered returns of over 20% in U.S. dollar terms, driven by a combination of strong earnings growth and valuation multiple expansion.
  • Markets faced heavy economic and monetary policy newsflow, including a further Federal Reserve rate cut, easing U.S. inflation, a strong quarterly GDP print in the U.S, an ECB on hold but more optimistic on growth amid sticky inflation, and a Bank of Japan rate hike that pushed Japanese yields higher.
  • Emerging Markets and Europe outperformed the U.S. over the full year as well as in December.
  • After another exceptional year for technology and AI-related stocks, U.S. AI names saw some profit-taking in December.

Performance commentary

  • In December, the Fund delivered a nearly flat absolute performance but outperformed its reference indicator.
  • The Financials sector has been the biggest contributor to the absolute performance with UBS and S&P Global posting strong year-end performance.
  • The relative overperformance was mainly driven by the technology sector with Nvidia being the main contributor.
  • Indeed, its announcement of a $20B licensing and asset acquisition deal with Groq, signalled aggressive expansion in inference technology confirming their AI leadership.
  • On the other hand, our consumer staples positions, including Procter & Gamble and Unilever, posted negative performance as consumers remain stretched.

Outlook strategy

  • Our macroeconomic framework continues to advocate a defensive positioning, as valuation remains a key concern at the overall market level.
  • During the month, we made several portfolio adjustments. We initiated a position in Regeneron, a US biotech with strong product franchises.
  • We also took the opportunity to add to Cencora and Mckesson the two drug distributors, after weak performance in the beginning of December.
  • Defensive sectors are trading at their most attractive relative valuations in nearly two decades, offering resilience and diversification benefits should growth expectations disappoint.
  • In the current environment, earnings visibility is likely to be increasingly rewarded. We therefore maintain a disciplined stance, limiting exposure to cyclical sectors in favour of quality.
  • Our portfolio remains positioned to benefit from secular growth trends such as AI and digital transformation, while maintaining the flexibility and discipline needed to navigate an uncertain macro backdrop.

Performance Overview

Data as of:  Jan 8, 2026.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 09/01/2026

Carmignac Portfolio Grandchildren Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  Nov 28, 2025.
North America64.0 %
Europe36.0 %
View details

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  Nov 28, 2025.
Equity Investment Weight95.6 %
Net Equity Exposure95.6 %
Number of Equity Issuers41
Active Share79.5 %

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Managers.
Fund Management Team
[Management Team] [Author] Denham Mark

Mark DENHAM

Head of Equities, Fund Manager
[Management Team] [Author] Ejikeme Obe

Obe EJIKEME

Fund Manager, Analyst
Carmignac Portfolio Grandchildren is an intergenerational Fund that focuses on high-quality companies to help investors build capital not only for themselves, but also for future generations.
[Management Team] [Author] Denham Mark

Mark DENHAM

Head of Equities, Fund Manager
View Fund's characteristics

Articles that may interest you

Strategies insightsOctober 16, 2025English

Carmignac Portfolio Grandchildren: Letter from the Fund Managers - Q3 2025

3 minute(s) read
Find out more
Strategies insightsJuly 14, 2025English

Carmignac Portfolio Grandchildren: Letter from the Fund Managers - Q2 2025

3 minute(s) read
Find out more
Strategies insightsApril 16, 2025English

Quality: your compass in an uncertain world

Find out more
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
​The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performance is shown net of fees (excluding any subscription fees payable to the distributor). Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.